文献速递免疫规划卫生政策与健康促进

巴西母婴免疫预防婴儿百日咳的静态与动态模型比较

Comparison of static and dynamic models of maternal immunization to prevent infant pertussis in Brazil.
PubMed 文献 · Vaccine · 2021-01-01

该研究比较巴西母婴免疫预防婴儿百日咳的静态与动态成本效果模型,探索静态模型何时足以支持公共卫生决策。动态模型显示,婴儿疫苗覆盖率低时母婴免疫可节省成本并挽救生命,但覆盖率超过90-95%阈值时成本极高;静态模型则仅显示高覆盖率下成本略高。当干预自身不产生显著群体免疫效应时,动态模型对准确估计成本效果至关重要。

要点

  • 婴儿疫苗覆盖率低时,母婴免疫可节省成本并挽救生命。
  • 婴儿覆盖率超过90-95%时,母婴免疫成本极高,动态模型估得2百万美元/DALY(疫苗9.55美元/剂)。
  • 当干预自身不产生显著群体免疫效应时,需用动态模型准确估计成本效果。

核心结论

  • 静态模型可用于探索干预措施的成本效果方向与主要驱动因素。
  • 当干预自身不产生显著群体免疫效应且背景人群疫苗接种率变化大时,动态模型对准确估计成本效果至关重要。

研究设计与样本

  • 比较两种母婴免疫预防婴儿百日咳的成本效果模型:一个静态模型,一个动态模型。
  • 设定两个场景:场景1评估婴儿疫苗覆盖率从低/中到超过群体免疫消除百日咳阈值时母婴aP免疫的增量成本/DALY;场景2比较模型不同时间跨度的成本效果估计。
  • 评估母婴疫苗价格9.55美元/剂(基础案例)和1美元/剂。

主要发现

  • 动态模型显示,婴儿疫苗覆盖率低时母婴免疫可节省成本并挽救生命。
  • 婴儿覆盖率>95%且疫苗价格9.55美元/剂时,动态模型估计母婴免疫成本为2百万美元/DALY;价格1美元/剂时为200,000美元/DALY。
  • 静态模型估计高婴儿覆盖率下成本/DALY仅略高于低覆盖率。
  • 婴儿覆盖率<90-95%时,两模型在不同时间跨度的投影落在同一范围。

临床怎么用

  • 在婴儿疫苗覆盖率低/中地区,可优先考虑母婴免疫以节省成本并挽救生命。
  • 当婴儿疫苗覆盖率接近或超过90-95%时,需用动态模型评估母婴免疫的成本效果。
  • 全球婴儿疫苗接种率差异大,决策时应考虑模型选择对成本效果估计的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This paper compares cost-effectiveness results from two models of maternal immunization to prevent pertussis in infants in Brazil, one static, one dynamic, to explore when static models are adequate for public health decisions and when the extra effort required by dynamic models is worthwhile. METHODS: We defined two scenarios to explore key differences between static and dynamic models, herd immunity and time horizon. Scenario 1 evaluates the incremental cost/DALY of maternal acellular pertussis (aP) immunization as routine infant vaccination coverage ranges from low/moderate up to, and above, the threshold at which herd immunity begins to eliminate pertussis. Scenario 2 compares cost-effectiveness estimates over the models' different time horizons. Maternal vaccine prices of $9.55/dose (base case) and $1/dose were evaluated. RESULTS: The dynamic model shows that maternal immunization could be cost-saving as well as life-saving at low levels of infant vaccination coverage. When infant coverage reaches the threshold range (90-95%), it is expensive: the dynamic model estimates that maternal immunization costs $2 million/DALY at infant coverage > 95% and maternal vaccine price of $9.55/dose; at $1/dose, cost/DALY is $200,000. By contrast, the static model estimates costs/DALY only modestly higher at high than at low infant coverage. When the models' estimates over their different time horizons are compared at infant coverage < 90-95%, their projections fall in the same range. CONCLUSIONS: Static models may serve to explore an intervention's cost-effectiveness against infectious disease: the direction and principal drivers of change were the same in both models. When, however, an intervention too small to have significant herd immunity effects itself, such as maternal aP immunization, takes place against a background of vaccination in the rest of the population, a dynamic model is crucial to accurate estimates of cost-effectiveness. This finding is particularly important in the context of widely varying routine infant vaccination rates globally. CLINICAL TRIAL REGISTRY: Clinical Trial registry name and registration number: Not applicable.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Russell LB, Kim SY, Toscano C, et al. Comparison of static and dynamic models of maternal immunization to prevent infant pertussis in Brazil. Vaccine. 2021. PMID: 33303183. doi:10.1016/j.vaccine.2020.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。